| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −0.3× | −14.4× | |
| Price / Book | 0.2× | 3.7× | |
| Price / Sales | — | 274.7× | — |
| Price / Free cash flow | −0.5× | −73.2× | |
| EV / EBITDA | 0.1× | −22.6× | |
| Earnings yield | −347.3% | −4.6% | |
| Free cash flow yield | −212.7% | −2.4% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
BRNAS:BRVEBraveheart Bio Inc · 🇺🇸 NAS | $19.21 | +2.67% | $1.73B | −26.2× | −78.6% | — |
KRNAS:KRSAKorsana Biosciences Inc · 🇺🇸 NAS | $31.41 | −3.00% | $1.43B | −405.5× | −38.8% | +1296.0% |
CTNAS:CTYCity Therapeutics, Inc. · 🇺🇸 NAS | $21.46 | −4.20% | $1.08B | −18.5× | 69.1% | — |
OBNAS:OBXObsidian Therapeutics Inc · 🇺🇸 NAS | $11.94 | +1.44% | $737.57M | 4.9× | 2,275.2% | — |
ATNAS:ATTOAttovia Therapeutics Inc · 🇺🇸 NAS | $13.89 | +1.17% | $634.1M | −10.4× | −40.4% | — |
BLNAS:BLSMBlossomHill Therapeutics Inc · 🇺🇸 NAS | $14.16 | +1.58% | $450.07M | −7.4× | 46.0% | — |
VONAS:VOGXVogenx Inc · 🇺🇸 NAS | $15.92 | +9.57% | $236.49M | −163.6× | 157.3% | — |
CNNAS:CNSYCerenome, Inc. · 🇺🇸 NAS | $1.65 | −2.94% | $12.52M | −0.6× | −560.2% | +168.7% |
BSNAS:BSEMBioStem Technologies, Inc. · 🇺🇸 NAS | $1.54 | −26.32% | — | — | −16.8% | −67.3% |
